On Friday, Sealed Air Corp (NYSE:SEE)’s shares showed no change to $51.14.
The Company reports that Mr. Stan Lis of Vancouver, BC , has been designated as President and CEO following the resignation of Glen Macdonald . Glen Macdonald is still a director of the Company. Mr. Lis has also been designated as a director to fill a vacancy in the Board resulting from the resignation of Mr. Ken Ralfs . Mr. Lis was the co-founder, past President and director of Targeted Microwave Solutions Inc. (formerly Carbon Friendly Solutions Inc.) since its inception in 2006 to 2015. He is an practiced businessman and has been involved with several public companies over the years, having raised a noteworthy amount of equity capital.
Mr. Casey Forward , CPA/CGA, based in Vancouver has been designated as CFO following the resignation of Mr. Glen Indra. Mr. Forward has also been designated as a director to fill a vacancy in the Board resulting from the resignation of Mr. Zygmunt Riddle Przetakiewicz . Mr. Forward has been a CPA/CGA (professional accountant) in British Columbia since 1985. Mr. Forward has been a director, Chief Executive Officer and/or Chief Financial Officer of several public companies trading on the TSX and TSX Venture Exchange. Most recently, he was the CFO for NioCorp Development Ltd. from 2010 to 2015.
Sealed Air Corporation provides food safety and security, facility hygiene, and product protection solutions worldwide. The companys Food Care segment offers integrated system solutions that incorporate equipment systems into customers operations; and packaging equipment systems that incorporate various options for loading, filling and dispensing, and retort and aseptic processing conditions. It also provides graphic design, printing, training, field quality assurance, and remote diagnostics services; and clean-in-place and open plant systems that integrate cleaning chemicals, lubricants, floor care equipment, and cleaning tools.
Altera Corporation (NASDAQ:ALTR)’s shares gained 0.12% to $50.55.
Altera Corporation (ALTR) has developed a storage reference design, based on its Arria® 10 SoCs that doubles the life of NAND flash and can enhance the number of program-erase cycles by up to 7 X contrast to current NAND flash implementations. The reference design comprises an Arria 10 SoC with an integrated dual-core ARM® Cortex®A9 processor, in an optimized, cost-effective, single-chip solution, leveraging a solid-state disk (SSD) controller from Mobiveil and NAND optimization software from NVMdurance. This reference design provides improved performance and flexibility in NAND utilization while reducing the cost of the NAND array by increasing the lifetime of data center equipment.
Using FPGAs with integrated hard processor systems, designers can quickly take advantage of the cost savings offered by next-generation NAND devices while retaining the flexibility to customize a solution that maximizes the performance, durability and storage capacity of their system. This storage solution implements Mobiveil’s Universal NVM Express Controller (UNEX), a configurable controller for PCIe-based SSDs, and NVMdurance’s NAND flash optimization software in an Arria 10 SoC, enabling data centers to leverage the most advanced 3D NAND technology without the long design cycles required with ASIC designs.
Altera Corporation, a semiconductor company, designs and sells programmable logic devices (PLDs), HardCopy application-specific integrated circuit (ASIC) devices, power system-on-chip devices (PowerSoCs), pre-defined design building blocks, and associated development tools.
At the end of Friday’s trade, Tripadvisor Inc (NASDAQ:TRIP)‘s shares dipped -0.84% to $66.92.
The Independent Traveler, Inc. – publisher of three leading online travel sites, and part of the TripAdvisor Media Group – declares the appointment of Mike Ewing as general manager. Ewing will oversee the online publisher’s three brands – Cruise Critic, Family Vacation Critic and IndependentTraveler.com.
Preceding to joining The Independent Traveler, Inc., Ewing held administration roles at LogMeIn, Vistaprint, and Monster.com. Ewing’s professional career comprises time in the US in addition to time abroad with responsibility for large geographic regions. An avid traveler, Ewing has been around the world while managing global teams focused on consumer, media and B2B businesses. Ewing is a regular speaker and contributor on topics as wide-ranging as sales and marketing, building high-performance teams and venture funding.
TripAdvisor, Inc. operates as an online travel company. The company operates through two segments, Hotel and Other. Its travel research platform aggregates reviews and opinions about accommodations, destinations, activities and attractions, and restaurants that enable consumers to plan and book hotels, vacation rentals, flights, activities and attractions, and restaurants.
Baxalta Inc (NYSE:BXLT), ended its Friday’s trading session with 2.29% gain, and closed at $35.81.
Baxalta Incorporated (BXLT) declared it has filed a Registration Statement on Form S-1 with the Securities and Exchange Commission (SEC) recently in connection with the projected secondary offering of up to $1.45 billion of common stock of the company presently held by Baxter International Inc. (BAX). J.P. Morgan Securities LLC is acting as the sole underwriter for the offering.
The projected offering is comprising with the formerly revealed plan of Baxter to engage in certain debt-for-equity exchanges to dispose of its retained stake in Baxalta in a tax-free manner within the 18-month period following Baxalta’s separation from Baxter. Baxalta is not selling any shares in the offering and will not receive any proceeds from the offering.
Baxalta Incorporated, a biopharmaceutical company, develops, manufactures, and markets a portfolio of products primarily for the treatment of hematology and immunology worldwide. It also offers other therapies for the treatments of bleeding disorders, and chronic and acute medical conditions, counting hemophilia A, hemophilia B, attained hemophilia, inhibitor treatments, primary immunodeficiency (PID), and alpha-1 antitrypsin deficiency.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
